Irtaza Haider

Syed Irtaza Haider is a highly experienced professional in the field of clinical research and product development, currently serving as the Director of Site Orchestration at Care Access since October 2016, where contributions include pioneering Mobile Clinical Research during the COVID-19 pandemic and successfully delivering an Emergency Use Authorization for bamlanivimab in collaboration with Eli Lilly. Prior roles include project management of decentralized clinical trials, site list management for the COVID-19 Clinical Trials Alliance, and product deployment at Reify Health, among others. Educational background includes a Bachelor's degree in Chemical Biology from the University of California, Berkeley. Syed Irtaza Haider has demonstrated expertise in clinical trial engagement, research analysis, and product development throughout a diverse career in various research and healthcare-related organizations.